3 Growth Companies With High Insider Ownership And Up To 22% Revenue Growth

As February begins, major U.S. stock indexes have shown strength, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing a record high. In this robust market environment, companies with strong insider ownership and impressive revenue growth can be particularly appealing to investors looking for potential opportunities in the growth sector.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth XPeng (XPEV) 20.8% 48.2% Upstart Holdings (UPST) 12.5% 50.5% StubHub Holdings (STUB) 22.3% 59.8% SES AI (SES) 12.2% 68.9% McEwen (MUX) 15.7% 66.2% Karman Holdings (KRMN) 17.3% 62% BillionToOne (BLLN) 11.2% 51% Atour Lifestyle Holdings (ATAT) 17.5% 24.3% Astera Labs (ALAB) 10.4% 28.0% AppLovin (APP) 27.4% 21%

Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Bridgewater Bancshares

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bridgewater Bancshares, Inc. is the bank holding company for Bridgewater Bank, offering a range of banking products and services in the United States, with a market cap of $532.71 million.

Operations: The company generates revenue of $137.30 million from its banking products and services in the United States.

Insider Ownership: 20.5%

Revenue Growth Forecast: 13% p.a.

Bridgewater Bancshares demonstrates strong growth potential, with earnings having grown 46.1% over the past year and forecasted to grow 20.05% annually, outpacing the US market's expected growth. Despite trading at a significant discount to its estimated fair value, recent insider activity shows substantial selling over the past three months. The company reported net income of US$46.09 million for 2025 and announced a dividend on its preferred stock, indicating financial stability amidst higher net charge-offs compared to last year.

Click to explore a detailed breakdown of our findings in Bridgewater Bancshares' earnings growth report. The valuation report we've compiled suggests that Bridgewater Bancshares' current price could be quite moderate.BWB Earnings and Revenue Growth as at Feb 2026

GBank Financial Holdings

Simply Wall St Growth Rating: ★★★★★☆

Overview: GBank Financial Holdings Inc., with a market cap of $483.62 million, operates as a bank holding company for GBank, offering banking services to commercial and consumer customers in Nevada.

Operations: The company generates revenue of $72.17 million from its banking services segment, catering to both commercial and consumer clients in Nevada.

Insider Ownership: 27.2%

Story Continues

Revenue Growth Forecast: 22.2% p.a.

GBank Financial Holdings shows strong growth potential with earnings having grown 24.5% annually over the past five years and forecasted to grow significantly at 42.4% per year, surpassing the US market's growth rate. Despite a high level of bad loans at 3.4%, recent financial results indicate resilience, with net interest income rising to US$50.74 million in 2025 from US$46.2 million in 2024, alongside strategic debt financing initiatives to bolster capital structure.

Click here to discover the nuances of GBank Financial Holdings with our detailed analytical future growth report. According our valuation report, there's an indication that GBank Financial Holdings' share price might be on the expensive side.GBFH Ownership Breakdown as at Feb 2026

Viemed Healthcare

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market cap of approximately $314.79 million.

Operations: The company generates revenue of $254.79 million from its healthcare facilities and services segment in the United States.

Insider Ownership: 14.2%

Revenue Growth Forecast: 18.5% p.a.

Viemed Healthcare is poised for growth with earnings projected to increase significantly at 29.9% annually, outpacing the US market's growth rate. The company's price-to-earnings ratio of 23.1x remains below the healthcare industry average, suggesting a potentially attractive valuation. While revenue growth at 18.5% per year lags behind its earnings expansion, it still surpasses the broader market's pace. Recent participation in investor summits highlights ongoing engagement with stakeholders.

Unlock comprehensive insights into our analysis of Viemed Healthcare stock in this growth report. In light of our recent valuation report, it seems possible that Viemed Healthcare is trading beyond its estimated value.VMD Earnings and Revenue Growth as at Feb 2026

Key Takeaways

Gain an insight into the universe of 204 Fast Growing US Companies With High Insider Ownership by clicking here. Seeking Other Investments? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include BWBGBFH and VMD.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments